Rezolute presents additional Phase 3 sunRIZE data at pediatric meeting

May 1, 2026 12:15 PM

Rezolute, Inc. (NASDAQ: RZLT) presented expanded analyses from its Phase 3 sunRIZE study of ersodetug at the Pediatric Endocrine Society ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found